Free Trial
→ Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (From Paradigm Press) (Ad)tc pixel Free GCL Stock Alerts

Geiger Counter (GCL) Stock Chart & Stock Price History

Geiger Counter logo
GBX 73 +0.50 (+0.69%)
As of 11:43 AM Eastern
Compare

Geiger Counter Stock Price Performance

The Geiger Counter (GCL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 97.30%, with a year-to-date return of 24.36%. In the past month, the stock has increased 3.40%, reflecting recent market activity.

As of the latest close, Geiger Counter traded at GBX 72.35 with a market cap of £82.54 million and volume of 442,766 shares. Five years ago, the stock traded at GBX 41.40, representing a 76.33% increase over that period. At the time, it had a market cap of £55.85 million and a volume of 1.69 million shares.

Receive GCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Geiger Counter and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+0.83%
1 Month
Performance
+3.40%
3 Month
Performance
-2.80%
Year-To-Date
Performance
+24.36%
1 Year
Performance
+97.30%
5 Year
Performance
+76.33%

GCL Stock Chart for Thursday, May, 14, 2026

GCL Chart by TradingView

Geiger Counter Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 73GBX 72.35
-0.89%		GBX 73.50GBX 71.06442,766 shs£82.54 million
05/12/2026GBX 72.13GBX 73
+1.21%		GBX 74.25GBX 72320,553 shs£83.28 million
05/11/2026GBX 72.40GBX 72.13
-0.38%		GBX 75GBX 71349,845 shs£82.28 million
05/08/2026GBX 74.20GBX 72.40
-2.43%		GBX 75.72GBX 72250,975 shs£82.59 million
05/07/2026GBX 73.40GBX 74.20
+1.09%		GBX 76GBX 72.15326,146 shs£84.65 million
05/06/2026GBX 74GBX 73.40
-0.81%		GBX 73.55GBX 71.04260,478 shs£76.95 million
05/05/2026N/AGBX 74GBX 74.79GBX 71264,258 shs£77.58 million
04/30/2026GBX 75GBX 74.26
-0.99%		GBX 74.26GBX 70.69176,635 shs£77.85 million
04/29/2026GBX 76.80GBX 75
-2.34%		GBX 76.12GBX 72191,218 shs£78.63 million
04/28/2026GBX 75.89GBX 76.80
+1.20%		GBX 78.92GBX 75.40337,816 shs£80.51 million
04/27/2026GBX 76.40GBX 75.89
-0.67%		GBX 79.80GBX 75.40134,106 shs£79.56 million
04/24/2026GBX 79.73GBX 76.40
-4.17%		GBX 78GBX 75.10466,638 shs£80.10 million
04/23/2026GBX 76GBX 79.73
+4.90%		GBX 79.95GBX 75345,151 shs£83.58 million
04/22/2026GBX 73.40GBX 76
+3.55%		GBX 76GBX 72.60127,790 shs£79.68 million
04/21/2026GBX 73.73GBX 73.40
-0.45%		GBX 76.90GBX 72.12205,963 shs£76.94 million
04/20/2026GBX 75.42GBX 73.73
-2.25%		GBX 76.28GBX 72.13288,263 shs£77.29 million
04/17/2026GBX 74.45GBX 75.42
+1.30%		GBX 78GBX 74389,463 shs£79.07 million
04/16/2026GBX 74GBX 74.45
+0.61%		GBX 75GBX 72339,762 shs£78.05 million
04/15/2026GBX 70.60GBX 74
+4.82%		GBX 74GBX 69.70421,170 shs£77.58 million
04/14/2026GBX 70.48GBX 70.60
+0.17%		GBX 73GBX 69.60212,841 shs£74.01 million
04/13/2026GBX 72.09GBX 70.48
-2.23%		GBX 71.96GBX 68.32281,508 shs£73.89 million
Related Companies

This page (LON:GCL) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
You're not getting into the SpaceX IPO. Do this instead.
The SpaceX IPO is expected to price at $1.75 trillion - and retail investors won't get an allocation. Banks an...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The Rare Earth Shift Few Saw Coming
Rare earth elements are the hidden backbone of electric vehicles, modern defense technology, and advanced elec...
i2i Marketing Group, LLC | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
The worst mistake you can make with the SpaceX IPO
The $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...
Weiss Ratings | Sponsoredtc pixel